Literature DB >> 24100708

Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.

Ozgur Yalcinbayir1, Oner Gelisken, Berna Akova-Budak, Guven Ozkaya, Sadik Gorkem Cevik, Ahmet Ali Yucel.   

Abstract

PURPOSE: To investigate the correlation between spectral domain optical coherence tomography findings and best-corrected visual acuity (BCVA) in patients with central serous chorioretinopathy (CSC) and to determine the visual prognostic factors.
METHODS: We retrospectively studied 56 eyes of 49 patients who had the diagnosis of CSC. Patients were categorized into subgroups depending on symptoms and clinical findings. Together with the overall foveal integrity of inner segment/outer segment (IS/OS) and external limiting membrane, several features of CSC including hyperreflective dots and hypertrophy of retinal pigment epithelium were investigated with spectral domain optical coherence tomography. Thickness measurements within the retina and choroid were performed.
RESULTS: Best-corrected visual acuity was closely associated with IS/OS line integrity (P < 0.001). The length of IS/OS disruption also had significant correlation with BCVA (r = -0.324, P = 0.016). Loss of foveal IS/OS and external limiting membrane line integrity was related to low BCVA (P < 0.001 for both). Presence of hyperreflective dots (P < 0.001) and retinal pigment epithelium hypertrophy (P = 0.011) had significant association with visual status. In cases with sequelae of CSC, BCVA was correlated with parameters of outer retinal damage.
CONCLUSION: Besides the overall integrity of IS/OS line and the length of disruption, loss of foveal IS/OS and external limiting membrane integrity are also noteworthy in cases with CSC. Hyperreflective dots and retinal pigment epithelium hypertrophy are closely associated with BCVA in cases with CSC. Analysis of the subgroups has shown that morphologic changes that persist until the late phases of the disease could potentially affect the visual outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24100708     DOI: 10.1097/IAE.0000000000000001

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  25 in total

1.  Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy.

Authors:  Meltem Guzin Altınel; Banu Acikalin; Hasan Gunes; Gokhan Demir
Journal:  Lasers Med Sci       Date:  2021-01-07       Impact factor: 3.161

2.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 3.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

4.  [Uniform classification of the pachychoroid spectrum disorders].

Authors:  Alaa Din Abdin; Shady Suffo; Fabian N Fries; Hakan Kaymak; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-04-26       Impact factor: 1.059

5.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

Review 6.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

Review 7.  Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.

Authors: 
Journal:  Ophthalmologie       Date:  2022-04-06

8.  Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.

Authors:  Bertan Cakir; Franziska Fischer; Christoph Ehlken; Anima Bühler; Andreas Stahl; Günther Schlunck; Daniel Böhringer; Hansjürgen Agostini; Clemens Lange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-05       Impact factor: 3.117

9.  Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.

Authors:  Tomoko Nakamura; Tomoko Ueda-Consolvo; Toshihiko Oiwake; Atsushi Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-02       Impact factor: 3.117

10.  Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.

Authors:  Marina Papadia; Bruno Jeannin; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.